Authors/Disclosures
|
Dylan G. Jones, MD
|
No disclosure on file |
|
Haley Huggins, MD
(Boston Medical Center)
|
Dr. Huggins has nothing to disclose. |
|
David E. Thaler, MD, PhD, FAAN
(Tufts Medical Center)
|
Dr. Thaler has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Lester Y. Leung, MD
(Tufts Medical Center)
|
Dr. Leung has received research support from NIH. |
|
Rainer W. Paine, MD, PhD
(Food and Drug Administration)
|
No disclosure on file |
|
|
No disclosure on file |
|
Seena Vengalil, MD
(Department of Neurology, NIMHANS)
|
Dr. Vengalil has nothing to disclose. |
|
W. T. Kimberly, MD, PhD
(Massachusetts General Hospital)
|
Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hyperfine Inc.. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from Biogen. The institution of Dr. Kimberly has received research support from NControl Therapeutics. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from American Heart Association. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care. |